GRAPPA 2013 annual meeting, rheumatology updates: Psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project

Journal of Rheumatology

Volumn 41, Issue 6, 2014, Pages 1244-1248

  FitzGerald, Oliver ^a   Mease, Philip J ^b   Helliwell, Philip S ^c   Chandran, Vinod ^d,e  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Ankylosis; Biomarkers; Osteolysis; PsA BioDam; Psoriatic arthritis; Spondyloarthritis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2; DICKKOPF 1 PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SCLEROSTIN; SERUM AMYLOID A; STROMELYSIN;

ASSESSMENT OF SPONDYLOARTHRITIS CRITERIA; BONE TURNOVER; CLASSIFICATION FOR PSORIATIC ARTHRITIS CRITERIA; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; HUMAN; JOINT RADIOGRAPHY; MEDICAL RESEARCH; NOMENCLATURE; ONSET AGE; PERIPHERAL SPONDYLARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS MUTILANS; REACTIVE ARTHRITIS; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; ARTHRITIS; ARTHRITIS, PSORIATIC; BLOOD; CLASSIFICATION;

ARTHRITIS; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; HUMANS;

EID: 84901702946     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140181     Document Type: Conference Paper

References (13)

1. Wright V, Moll JMH. Seronegative polyarthritis. Amsterdam: North Holland Publishing Co; 1976.
2. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999;42:1080-6. Erratum in: Arthritis Rheum 1999;42:1997. (Pubitemid 29268943)
3. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology 1999;38:332-7. (Pubitemid 29507183)
4. McQueen F, Lloyd R, Doyle A, Robinson E, Lobo M, Exeter M, et al. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study. Ann Rheum Dis 2011;70:1091-4.
5. Chandran V, Thavaneswaran A, Pellett FJ, Gladman DD. The association between human leukocyte antigen and killer-cell immunoglobulin-like receptor gene variants and the development of arthritis mutilans in patients with psoriatic arthritis [abstract]. Arthritis Rheum 2011;63 Suppl:S532.
6. Chandran V, Gladman DD, Helliwell PS, Gudbjornsson B. Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. J Rheumatol 2013;40:1419-22.
7. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
8. Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770-6.
9. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
10. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
11. Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res 2012;64:905-10.
12. Stafford L, Kane D, Murphy E, Duffy T, Lassere M, Youssef PP, et al. Psoriasis predicts a poor short-term outcome in patients with spondylarthropathy. Arthritis Rheum 2001;45:485-93. (Pubitemid 33140583)
13. van den Berg R, van Gaalen F, van der Helm-van Mil A, Huizinga T, van der Heijde D. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis Cohort. Ann Rheum Dis 2012;71:1366-9.